NIH Clinical Center: Search the Studies

Search the Studies

21 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
000726-C	A Randomized Phase 2 Study of Atezolizumab with or without Selinexor in Alveolar Soft Part Sarcoma (AXIOM)	Participants currently recruited/enrolled	18-125 Years	NCI	Nuclear
000585-CH	An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of CLN3 Disease in Patients 17 Years of Age and Older	Participants currently recruited/enrolled	17-125 Years	NICHD	Cataract
000030-C	Phase 2 Study of Bintrafusp alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).	Participants currently recruited/enrolled	18-125 Years	NCI	Nuclear
21-C-0007	A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers	Participants currently recruited/enrolled	18-125 Years	NCI	Nuclear
20-CH-0126	Data Collection Study of Pediatric and Adolescent Gynecology Conditions	Participants currently recruited/enrolled	0-125 Years	NICHD	Nuclear
20-C-0104	Phase I/II Trial of HPV Vaccine PRGN-2009 Alone or in Combination with Anti-PD-L1/TGF-Beta Trap (M7824) in Subjects with HPV Positive Cancers	Participants currently recruited/enrolled	18-125 Years	NCI	Nuclear
20-C-0045	Phase I/II Trial of Combination Immunotherapy in Subjects with Advanced HPV Associated Malignancies	No longer recruiting/follow-up only	18-125 Years	NCI	Nuclear
15-H-0155	Hereditary Parkinson Disease Natural History Protocol	Completed Study; data analyses ongoing	18-80 Years	NHLBI	Early-Onset
11-C-0136	Multi-Institutional Prospective Pilot Study of Lupron to Enhance Lymphocyte Immune Reconstitution Following Allogeneic Bone Marrow Transplantation in Post-Pubertal Children and Adults with Molecular Imaging Evaluation	Completed Study; data analyses ongoing	2-55 Years	NCI	Nuclear
08-EI-0043	Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up	No longer recruiting/follow-up only	50-125 Years	NEI	Cataract
08-DK-0098	Natural History of Familial Carcinoid Tumor	Participants currently recruited/enrolled	18-125 Years	NIDDK	Nuclear
07-CH-0008	Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion	Completed Study; data analyses ongoing	18-85 Years	NICHD	Nuclear
06-H-0072	Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial	Completed Study; data analyses ongoing	18-70 Years	NHLBI	Cataract
06-EI-0236	National Ophthalmic Genotyping and Phenotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases	No longer recruiting/follow-up only	2-125 Years	NEI	Cataract
05-H-0130	Long-Term Evaluation and Follow Up Care of Patients Treated with Allogeneic Stem Cell Transplants	Participants currently recruited/enrolled	7-80 Years	NHLBI	Nuclear
04-C-0165	Data Collection, Clinical Care and Interventions in CCR, NCI	Enrolling by Invitation	0-125 Years	NCI	Nuclear
02-CH-0311	Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders	Participants currently recruited/enrolled	0-125 Years	NICHD	Cataract
02-C-0313	Cancer Risk in Xeroderma Pigmentosum Heterozygotes	Participants currently recruited/enrolled	0-99 Years	NCI	Nuclear
01-C-0129	Eligibility Screening for the NIH Intramural Research Program Clinical Protocols	Enrolling by Invitation	0-125 Years	NCI	Nuclear
77-DK-0096	Studies on Thyroid Nodules and Thyroid Cancer	Participants currently recruited/enrolled	0-125 Years	NIDDK	Nuclear
77-DK-0002	Evaluation of Patients with Thyroid Function Disorders	Participants currently recruited/enrolled	0-125 Years	NIDDK	Nuclear